Hao Wu

Prof. Dr. Hao Wu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
JZjianjun zhu
jianjun zhu
CZChunle Zhang
Chunle Zhang
ZWZhengjie Wang
Zhengjie Wang
LSLihong Shi
Lihong Shi
LLLi Li
Li Li
MLMing Liu
Ming Liu
MiR‐138‐5p has been identified as a novel cancer‐related miRNA molecule in a variety of malignancies. However, the functions and mechanisms underlying miR‐138‐5p in colorectal carcinoma (CRC) remains largely unknown. In the present study, we analysed the biological effects and clinical significance of miR‐138‐5p in CRC. miR‐138‐5p expression was analysed by quantitative real‐time PCR in CRC tissues and cell lines. The effects of miR‐138‐5p on CRC cell growth was detected by cell proliferation, colony formation, cell cycle and cell apoptosis assays in vitro and in vivo. Our data showed that miR‐138‐5p was significantly downregulated in CRC. Downregulated miR‐138‐5p was related with poor prognosis in patients with CRC. miR‐138‐5p suppressed CRC growth but promoted cell death both in vitro and in vivo. Online predictions and integrated experiments identified that miR‐138‐5p targeted MCU, and downregulated miR‐138‐5p promoted mitochondrial biogenesis in CRC. In the light of the underlying mechanisms, our results indicated that downregulated miR‐138‐5p led to increased expression of MCU, which subsequently increased the production of ROS to promote CRC growth. Our results indicated that downregulated miR‐138‐5p strengthened mitochondrial biogenesis through targeting MCU, thus contributing to CRC cell growth, which may provide a potential therapeutic target for CRC.

26 February 2026 in Hepatology Communications
Verified
Journal Article
Open access
TTTing Tang
Ting Tang
YLYubo Li
Yubo Li
NXNi Xiyun
Ni Xiyun
HWHao Wu
Hao Wu
LFLu Fan
Lu Fan
JZjianjun zhu
jianjun zhu
Background: Hepatocellular carcinoma (HCC) develops from chronic inflammatory conditions to malignancy, with the immune microenvironment playing a significant role in this progression. However, the changes in the dynamic immune microenvironment during the transition from hepatitis to HCC remain poorly understood. Systematic analysis of stage-specific immune microenvironment alterations is essential for identifying therapeutic targets and creating precision strategies for HCC. Methods: Using single-cell RNA sequencing (scRNA-seq), we created dynamic transcriptome maps of the immune microenvironment across healthy liver, hepatitis, cirrhosis, and HCC stages. Cell–cell communication, trajectory, and enrichment analyses were utilized to characterize relationships between clusters. TCGA-LIHC data were used to validate gene expression and its prognosis. The spatial distribution of ligand–receptor complexes in HCC was confirmed by spatial transcriptomics and multiplexed immunofluorescence. The effects of the tumor microenvironment on cancer cell behavior were examined using co-immunoprecipitation and cell co-culture assays. Finally, the impact of the immune microenvironment on in vivo tumor progression was evaluated using a mouse transplantation model. Results: We identified specific immune cell clusters across HCC progression and revealed significant correlations between the abundance of immune cells (macrophages, B cells)and fibroblasts with disease severity. Crosstalk between SPP1 + macrophages and ITGA5 + fibroblasts was observed explicitly in HCC. In vitro and in vivo data demonstrated that the SPP1-ITGA5 interaction triggered the secretion of MMP2 by fibroblasts, thereby promoting malignant progression in HCC. Conclusions: We present a dynamic transcriptional profile of immune microenvironment evolution during HCC development, aiding in the refinement of diagnostics and the optimization of therapy strategies.

9 January 2025 in Global Heart
Verified
Journal Article
Open access
PDF file
FHFengwei He
Fengwei He
TYTian Yang
Tian Yang
WZWentao Zhang
Wentao Zhang
MLMing Liu
Ming Liu
HWHao Wu
Hao Wu
Background and Aim: Cardiovascular diseases (CVD), including coronary artery disease (CAD), myocardial infarction (MI), atrial fibrillation (AF), and ischemic stroke (IS), are major causes of morbidity and mortality worldwide. Immune cells play crucial roles in CVD, but causal links between immune cell subtypes and CVD risk remain unclear. This study used Mendelian randomization (MR) to investigate these associations. Methods and Results: Exposure data were analyzed with a P < 1 × 10–5 threshold, excluding linkage disequilibrium SNPs. MR of 731 immune cell types used the inverse variance weighted (IVW) method, with pleiotropy and heterogeneity tests. Lipid profiles (HDL, LDL, VLDL, triglycerides) were assessed as mediators. Increased CD27 on unswitched memory B cells, CD28– DN T cells, and CX3CR1 on CD14– CD16+ monocytes raised CVD risk, while CD28 on Tregs and HLA DR++ monocytes were protective. For CAD, CD24+ CD27+ %B cells and SSC-A on HLA DR+ NK cells were protective, with certain T cells increasing risk. Similar trends were observed for MI, AF, and IS. Reverse MR showed no CVD effects on these positive immune traits. Lipid profiles mediated CVD risk, with HDL protective and LDL, VLDL, and triglycerides increasing risk. Mediation analyses showed LDL and triglycerides partially mediated CX3CR1-monocyte effects on MI risk. Functional enrichment identified cytokine signaling and inflammation in CVD. Conclusions: Our findings highlight immune cell subtypes and lipid traits in CVD risk. Regulatory T cells and protective phenotypes are therapeutic targets, while LDL and triglycerides mediate immune-disease pathways, emphasizing immune-lipid interactions for targeted therapies.

1 January 2025 in Journal of Alzheimer's Disease Reports
Verified
Journal Article
Open access
LNLi Niu
Li Niu
YLYubo Li
Yubo Li
HWHao Wu
Hao Wu
LZLiping Zhao
Liping Zhao
JZJin Zhang
Jin Zhang
MLMing Liu
Ming Liu
Background: Neuroinflammation represents a central pathological mechanism in Alzheimer's disease (AD). Lipopolysaccharide (LPS) is a potent inducer of neuroinflammation and demonstrates elevated circulating levels in AD patients. Objective: This study aims to investigate the genetic association between serum LPS activity level, inflammatory proteins and AD. Methods: A two-sample mendelian randomization (MR) analysis was performed to explore the causal effect of serum LPS activity level and 91 inflammatory proteins on AD, including 1, 260, 136 sporadic AD and 2, 838, 825 familial AD patients, respectively. Meta-analysis was conducted on multiple datasets to determine statistically significant results that was initially observed in one dataset. Results: Serum LPS activity level is a risk factor for early onset sporadic AD with OR = 1.392, 95% CI: 1.038–1.869. In most other sporadic AD datasets, LPS shows a trend of increasing the risk of AD onset. After meta-analysis in 10 independent datasets, no association between LPS and sporadic AD was observed. In most familial AD datasets, LPS level demonstrated a trend of decreasing AD risk in MR analysis, however, meta-analysis of the combined 8 datasets showed no statistically significant difference. Two inflammatory proteins, AXIN1 and IL-1 alpha, were identified as significant risk factors for sporadic AD. Conclusions: This study suggested that serum LPS activity level may present a risk effect in early onset sporadic AD. Two inflammatory proteins AXIN1 and IL-1 alpha were associated with the risk of sporadic AD. These findings provide a new perspective for the early diagnosis and treatment of sporadic and familial AD.

13 January 2026 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
MLMing Liu
Ming Liu
XZXintong Zhang
Xintong Zhang
YHYanfen Hu
Yanfen Hu
LNLi Niu
Li Niu
LGLinzhi Guo
Linzhi Guo
JZjianjun zhu
jianjun zhu
Kynurenine (Kyn) 3‑monooxygenase (KMO) is a key enzyme of the tryptophan (Try)‑Kyn pathway and is located on the outer membrane of mitochondria. Notably, it has not yet been elucidated as to whether KMO is involved in hepatocellular carcinoma (HCC) progression by affecting mitochondria. In the present study, KMO was revealed to be downregulated in HCC patients and this downregulation was associated with a poor prognosis. Notably, the downregulation of KMO promoted the proliferation and migration of HCC cells and increased mitochondrial mass. The levels of the Try metabolite 3‑hydroxyanthranilic acid (3‑HAA) were elevated in HCC cells overexpressing KMO. The results indicated that 3‑HAA may inhibit HCC cell growth promoted by KMO downregulation and reverse the KMO downregulation‑induced increase in mitochondrial mass. Furthermore, KMO and 3‑HAA were shown to regulate the expression of the transcription factor nuclear receptor subfamily 4 group A member 1 (NR4A1) and reduce NR4A1 mitochondrial translocation, thus inhibiting the growth of HCC cells. In summary, the current study elucidated that low KMO expression in HCC affects mitochondrial mass and function by reducing the level of the Try metabolite 3‑HAA, downregulating the expression of NR4A1 and promoting its mitochondrial translocation, which in turn may promote the progression of HCC. These findings provide new insights into the treatment of HCC, potentially targeting the mitochondria and the Try‑Kyn pathway.

7 September 2026 in Discover Oncology
Verified
Journal Article
Open access
PDF file
HCHuiying Chen
Huiying Chen
XNXiyun Ni
Xiyun Ni
LLLi Li
Li Li
ZXZhifang Xu
Zhifang Xu
MLMing Liu
Ming Liu
JZJianjun Zhu
Jianjun Zhu
Objective This study aimed to investigate the potential anti-colorectal cancer (CRC) effects and molecular mechanisms of organic acids from Lonicera japonica Thunb. Methods Active organic acid constituents were collected through literature review and database screening, followed by pharmacokinetic evaluation. Network pharmacology was applied to predict potential targets, which were intersected with CRC differentially expressed genes from the GEPIA database. GO and KEGG enrichment analyses explored the biological functions and signaling pathways. Core targets were identified through network topology analysis and random forest algorithms, with their prognostic and diagnostic relevance evaluated using TCGA and GEO datasets. Molecular docking was used to predict possible binding modes and binding energies between compounds and candidate targets. Furthermore, the anti-cancer effects of caffeic acid methyl ester (CAME) were preliminarily evaluated in HCT116 cells through CCK-8, colony formation, wound healing, Transwell, and flow cytometry assays. Western blot was performed to detect the expression of ERK and p-ERK. Results Four representative organic acid compounds and 117 potential targets were identified. Enrichment analysis suggested involvement in inflammatory responses, immune regulation, and cancer-related signaling pathways. DPP4 and MAPK1 were prioritized as candidate core targets with altered expression patterns and potential clinical relevance in CRC. Molecular docking suggested potentially favorable interactions between selected compounds and predicted core targets. Experimental results showed that CAME significantly inhibited HCT116 cell proliferation, colony formation, and migration in a dose- and time-dependent manner (IC50 = 16.06 µM at 48 h). CAME also induced cell apoptosis and significantly downregulated p-ERK protein levels. Under the tested conditions, the combination of CAME and SCH772984 further reduced cell viability and p-ERK levels compared with either single treatment; however, the nature of this interaction remains unknown. Conclusion Organic acids from Lonicera japonica Thunb., particularly CAME, may exert anti-CRC effects, at least in part, in association with reduced ERK phosphorylation. Bioinformatics analyses also suggested that predicted targets may be related to immune- and tumor microenvironment-associated pathways, which require further experimental validation. This study provides preliminary computational and in vitro evidence supporting further investigation of Lonicera japonica Thunb. organic acids as candidate natural compounds for CRC-related research.